Markets:

Overview

News

Currencies

International

Treasuries

Hoth Therapeutics, Inc. - Common Stock (NQ:HOTH)

0.7300 -0.0132 (-1.78%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hoth Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Hoth Therapeutics (NASDAQ: HOTH) Releases BioLexa Phase 1B Trial Results Showing Positive Results in Treating Mild to Moderate Atopic Dermatitis

October 31, 2022

Hoth Therapeutics, Inc. (NASDAQ: HOTH) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development

Via Spotlight Growth

Hoth Therapeutics' Atopic Dermatitis Candidate Shows Improvement In Severity, Shares Jump ↗

October 31, 2022

Hoth Therapeutics Inc (NASDAQ: HOTH) announced Phase 1b trial data for BioLexa in adult patients with mild-to-moderate atopic dermatitis.

Via Benzinga

What's Going On With Hoth Therapeutics Stock? ↗

October 31, 2022

Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading higher Monday after the company announced positive BioLexa Phase 1b clinical trial results.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 26, 2022

On Wednesday, 53 companies reached new 52-week lows.

Via Benzinga

Hoth Therapeutics Shares Surge On Encouraging Preclinical Data From Alzheimer's Program ↗

July 12, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

October 28, 2022

During Friday, 125 stocks hit new 52-week lows.

Via Benzinga

Hoth Therapeutics Adds New Pipeline Program For Stroke, Brain Injury ↗

April 19, 2022

Via Benzinga

Why Fulgent Genetics Shares Are Trading Higher Today ↗

April 19, 2022

Via Benzinga

Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday ↗

October 26, 2022

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.

Via Benzinga

Nasdaq Surges Over 200 Points; General Electric Posts Downbeat Earnings ↗

October 25, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 25, 2022

On Tuesday, 120 companies set new 52-week lows.

Via Benzinga

Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session ↗

October 25, 2022

Gainers

Via Benzinga

S&P 500 Rises Over 1%; General Motors Earnings Top Views ↗

October 25, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.8% on Tuesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

October 25, 2022

We're starting off the day with an overview of the biggest pre-market stock movers on Tuesday and the latest news this morning!

Via InvestorPlace

Why Qualtrics International Shares Are Trading Sharply Higher; Here Are 23 Stocks Moving Premarket ↗

October 25, 2022

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose 43% to $2.16 in pre-market trading. Astellas Pharma Inc. announced plans to invest a total of $50 million to acquire 15% of Taysha Gene...

Via Benzinga

Why Hoth Therapeutics Shares Are Falling In Monday's After-Hours Session ↗

October 24, 2022

Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading lower by 11.12% to $0.29 during Monday's after-hours session after the company

Via Benzinga

Hoth Therapeutics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying ↗

September 20, 2022

The Dow Jones jumped by around 197 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around...

Via Benzinga

The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program ↗

July 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

U.S. Stocks Turn Higher; PepsiCo Posts Upbeat Q2 Results ↗

July 12, 2022

U.S. stocks turned higher midway through trading after recording losses in the previous session.

Via Benzinga

Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session ↗

July 12, 2022

Gainers

Via Benzinga

Why Hoth Therapeutics Shares Are Skyrocketing Today ↗

July 12, 2022

Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading higher by 17% to $0.47 Tuesday morning after the company announced its HT-ALZ therapeutic showed cognitive improvements in an Alzheimer's Disease...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 24, 2022

Gainers Redhill Biopharma (NASDAQ:RDHL) stock moved upwards by 16.4% to $0.89 during Friday's pre-market session. The market value of their outstanding shares is at $47.6 million. As per the press...

Via Benzinga

Recap of Tuesday's Biotech Catalysts - End of the Day Summary ↗

June 21, 2022

Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid...

Via Benzinga

InvestorNewsBreaks – Hoth Therapeutics Inc. (NASDAQ: HOTH) Shares Pricing of $7M Public Offering

April 14, 2022

Via Investor Brand Network

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 12, 2022

Gainers

Via Benzinga

The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More ↗

April 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 12, 2022

Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

Hoth Therapeutics Plunges Afterhours On Secondary Public Offering Of Common Stock ↗

April 11, 2022

Hoth Therapeutics Inc (NASDAQ: HOTH) says it has commenced an underwritten public offering. Details were not disclosed. The company's proposed offering of the...

Via Benzinga

These 8 Stocks Are Seeing Massive Volume Today ↗

April 11, 2022

Trading volume is a simple way to measure how much of a security is being traded over a period of time. A high trading volume indicates high buying pressure if the stock is moving higher, or high...

Via Benzinga

Why Is SoFi (SOFI) Stock Down to New 52-Week Lows Today? ↗

April 11, 2022

SoFi Technologies (SOFI) stock isn't doing so well on Monday after the stock dropped to a new 52-week low and we know why!

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.